Agronomic portal Agronom.info
Categories
Language
Currency
My account
Rapeseed

Elvis

Diseases
Sclerotinia, Black leg
Country
France
Registration Year
2001
Manufacturer
Euralis Semences
Offers: 1
Where to buy
Price range
80 - 80 RUB
Views
4
Reviews
0
Producer
Euralis Semences
Description Elvis
The winter rapeseed variety Elvis is a high-yielding oilseed crop of type 00, characterized by the absence of erucic acid and low glucosinolate content. This early-maturing variety features early flowering and a vegetation period of approximately 265-270 days, enabling its effective use in various agroclimatic conditions, particularly in the North Caucasus region and southern Ukraine. Elvis exhibits high winter hardiness (4.3 points) and resistance to lodging and shattering, which helps preserve yield and reduce losses during harvest.

Rapeseed Elvis forms a tall plant with high oil content in seeds — from 46 to 49% — making it attractive for producing oilseed products. The variety demonstrates enhanced resistance to major diseases such as black leg and sclerotinia, as well as good tolerance to stressful growing conditions. Due to these qualities, Elvis ensures stable seed yields averaging 13.7 centners per hectare, with green mass yields reaching up to 65 tons per hectare.

Elvis is adapted to various soil-climatic conditions and is suitable for planting at later dates due to its rapid growth and high responsiveness to agronomic practices. Its resistance to pod cracking and diseases allows efficient use of this variety across different regions, ensuring reliable and high-quality harvests. All these characteristics make rapeseed Elvis an optimal choice for seed production and obtaining high-quality oilseed raw material.
Specifications Elvis
Diseases
Sclerotinia
Sclerotiniosis
Black leg
Black leg
Type of Rape
Winter rape
Erucic Acid Content
Low
Country
France
Registration Year
2001
Catalog
Varieties
Technical Crops
Manufacturer
Euralis Semences
Where to buy Elvis
Loading...
Reviews Elvis
0comments
Sort by:Popular first
No comments yet.